Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer’s Disease
In Alzheimer’s disease (AD), tau pathology manifested by the accumulation of intraneuronal tangles and soluble toxic oligomers emerges as a promising therapeutic target. Multiple anti-tau antibodies inhibiting the formation and propagation of cytotoxic tau or promoting its clearance and degradation...
Saved in:
Main Authors: | Lenka Hromadkova, Saak Victor Ovsepian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2019/7406810 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic Modulation on Tau Phosphorylation in Alzheimer’s Disease
by: Chao-Chao Yu, et al.
Published: (2019-01-01) -
Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis
by: Siddhartha Mondragón-Rodríguez, et al.
Published: (2020-01-01) -
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer’s disease and correlates with tau pathology
by: Alessandro Padovani, et al.
Published: (2025-01-01) -
On a function related to Ramanujan's Tau function
by: John A. Ewell
Published: (1985-01-01) -
Targeting early tau pathology: probiotic diet enhances cognitive function and reduces inflammation in a preclinical Alzheimer’s model
by: Cassandra M. Flynn, et al.
Published: (2025-01-01)